Search results for "Pneumococcal Infections"

showing 10 items of 15 documents

Pneumococcal Colonization in the Familial Context and Implications for Anti-Pneumococcal Immunization in Adults: Results from the BINOCOLO Project in…

2017

The spread of Streptococcus pneumoniae within families has been scarcely investigated so far. This feasibility study aimed to estimate the prevalence of pneumococcal carriage in school-aged children and co-habiting relatives and to explore the potential link between the family environment and the sharing of pneumococcal serotypes covered by the vaccine. Oropharyngeal samples of 146 subjects belonging to 36 different family groups were molecularly tested for pneumococcal detection and serotyping. The overall prevalence of pneumococcal carriage was 65.8% (n = 96/146), whereas it was higher among schoolchildren (77.8%, n = 28/36); subjects of seven years of age had the highest odds of being co…

0301 basic medicineSerotypeMalePediatricsfamilymedicine.disease_causeSettore MED/42 - Igiene Generale E ApplicataPneumococcal Vaccineslcsh:Chemistry0302 clinical medicineColonizationChild<i>Streptococcus pneumoniae</i>; conjugate vaccine; serotypes; schoolchildren; family; carriage; colonization; horizontal transmission; real-time PCRSicilylcsh:QH301-705.5SpectroscopyschoolchildrenGeneral MedicineMiddle AgedComputer Science ApplicationsStreptococcus pneumoniae030220 oncology & carcinogenesisChild Preschoolconjugate vaccinePopulation studyFemaleHorizontal transmissionAdultmedicine.medical_specialtyAdolescentContext (language use)CatalysisPneumococcal InfectionsArticleInorganic Chemistry03 medical and health sciencesYoung AdultSerotypeConjugate vaccineStreptococcus pneumoniaemedicineHumansPhysical and Theoretical ChemistrySerotypingMolecular BiologycarriageVaccines Conjugatebusiness.industryOrganic ChemistryOdds ratiohorizontal transmissioncolonization030104 developmental biologyserotypeslcsh:Biology (General)lcsh:QD1-999Feasibility StudiesImmunizationCarriage; Colonization; Conjugate vaccine; Family; Horizontal transmission; Real-time PCR; Schoolchildren; Serotypes; Streptococcus pneumoniaebusinessreal-time PCRDemographyInternational Journal of Molecular Sciences; Volume 18; Issue 1; Pages: 105
researchProduct

Assessment of Analysis of Urinary Pneumococcal Antigen by Immunochromatography for Etiologic Diagnosis of Community-Acquired Pneumonia in Adults

2006

ABSTRACT The limitations of conventional microbiologic methods (CMM) for etiologic diagnosis of community pneumococcal pneumonia have made faster diagnostic techniques necessary. Our aim was to evaluate the usefulness of the immunochromatography (ICT) technique for detecting urinary Streptococcus pneumoniae antigen in the etiologic diagnosis of community-acquired pneumonias (CAP). This was a prospective study on in-patients with CAP in a tertiary hospital conducted from October 2000 to March 2004. Apart from using CMM to reach an etiologic diagnosis, we determined pneumococcal antigen in concentrated urine by ICT. We also determined the urinary pneumococcal antigen (UPA) content in patients…

AdultMaleMicrobiology (medical)medicine.medical_specialtyAdolescentClinical BiochemistryImmunologymedicine.disease_causeCommunity-acquired pneumoniaInternal medicineStreptococcus pneumoniaemedicineHumansImmunology and AllergyProspective StudiesAgedAged 80 and overAntigens BacterialChromatographyCOPDbusiness.industryClinical and Diagnostic Laboratory ImmunologyRespiratory infectionMiddle AgedPneumonia Pneumococcalmedicine.diseaseCommunity-Acquired InfectionsPneumoniaPneumococcal infectionsStreptococcus pneumoniaePneumococcal pneumoniaImmunologyImmunologic TechniquesEtiologyFemalebusinessClinical and Vaccine Immunology
researchProduct

Antimeningococcal and antipneumococcal vaccination determinants: A European systematic literature review

2015

Background. ESCULAPIO is a multicenter project, funded by the Italian Centre for Disease Prevention and Control, aimed at implementing communication strategies to improve vaccination knowledge and attitudes among different target populations. Objective. The objective of the Sicilian research unit was, in the first phase, to identify, through systematic literature revision, which vaccination determinants play a role in the uptake of recommended vaccines included in the Italian Vaccination Plan. Design. A systematic literature review was carried out on studies describing the determinants underlying pneumococcal and meningococcal vaccination uptake. The analysis was limited to papers published…

AdultMaleParentsHealth Knowledge Attitudes PracticeAdolescentMeningococcal VaccinesSettore MED/42 - Igiene Generale E ApplicataVulnerable PopulationsHealth Services AccessibilityPneumococcal InfectionsPneumococcal VaccinesVaccination RefusalMeningococcal vaccination; Pneumococcal vaccination; Systematic literature review; Epidemiology; Public Health Environmental and Occupational HealthHumanssystematic literature review meningococcal vaccination pneumococcal vaccinationChildAgedAged 80 and overVaccinationAge FactorsInfantEuropeMeningococcal InfectionsSocioeconomic FactorsChild PreschoolCosts and Cost AnalysisFemale
researchProduct

Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain).

2011

Background: Heptavalent pneumococcal conjugate vaccine (PCV-7) was licensed to provide immunity against pneumococcal disease caused by seven serotypes of S. pneumoniae. Thirteen-valent pneumococcal conjugate vaccine (PCV-13) includes 6 additional serotypes for preventing invasive pneumococcal disease. Objective: The objective of this study was to estimate the potential health benefits, costs, and cost-effectiveness of vaccination with PCV-13 in the Community of Valencia and to generate valuable information for policy makers at regional and country levels. Methods: A decision tree was designed to determine the health and economic outcomes in hypothetical cohorts of vaccinated and unvaccinate…

AdultMalePediatricsmedicine.medical_specialtyAdolescentCost effectivenessPharmacoeconomic assessmentCost-Benefit AnalysisPneumococcal conjugate vaccinePneumococcal InfectionsHerd immunityPneumococcal VaccinesIndirect costsYoung AdultEnvironmental healthmedicineHeptavalent Pneumococcal Conjugate VaccineHumansChildAgedAged 80 and overGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPneumococcal conjugate vaccineVaccinationPublic Health Environmental and Occupational HealthInfant NewbornInfantMiddle AgedQuality-adjusted life yearVaccinationInfectious DiseasesSpainChild PreschoolCohortMolecular MedicineCost-effectivenessFemalebusinessmedicine.drugVaccine
researchProduct

Pneumococcus infections: Is the burden still as heavy?

2012

EA MERS CT3 Enjeu 3; International audience; The death rate of invasive pneumococcal infections decreased by 100 fold in one century. This tremendous improvement was due mainly to antibiotic use and multiple attempts at antipneumococcal vaccinations; thus, this was true only for developed countries. However, in France, the incidence has increased, over the last 10 years, in all age classes except for children vaccinated by the heptavalent pneumococcal conjugate vaccine. The incidence of these infections remains high, when associated to some risk factors such as HIV infection, malignant blood diseases, solid cancers, bronchial diseases, or alcohol abuse. The pneumococcal vaccine should be pr…

AdultSerotypeHeptavalent Pneumococcal Conjugate Vaccine[SDV]Life Sciences [q-bio]Immunization SecondaryAlcohol abuseGlobal HealthPneumococcal InfectionsPneumococcal Vaccines03 medical and health sciences0302 clinical medicineRisk FactorsHeptavalent Pneumococcal Conjugate Vaccine[SDV.BV]Life Sciences [q-bio]/Vegetal BiologyHumansMedicineserotype030212 general & internal medicineSerotypingChildinfection invasive à pneumocoque0303 health sciences030306 microbiologybusiness.industrypneumococcal invasive infectionDeveloped CountriesIncidenceMortality rateIncidence (epidemiology)VaccinationAge Factorssérotypemedicine.disease3. Good healthVaccinationPneumococcal infectionsStreptococcus pneumoniaeInfectious DiseasesPneumococcal vaccine[SDE]Environmental SciencesImmunologyDisease SusceptibilityFrancebusinessMédecine et Maladies Infectieuses
researchProduct

Procalcitonin and community-acquired pneumonia (CAP) in children

2015

The role of procalcitonin (PCT) as a biomarker for sepsis in adults is well documented, while its role in infections affecting neonatal children remains controversial. Among these infections, Community-Acquired pneumonia (CAP) has been studied extensively, because it's the second cause of death in children in developing countries, and one of the most frequent causes of hospitalization in industrialized countries. The PubMed database and the Cochrane Library were used to search for the following keywords: CAP, procalcitonin, and children. Thirteen articles were studied to determine the role of PCT in CAP management, specifically its usefulness for distinguishing pneumococcal infections from …

Calcitoninmedicine.medical_specialtyCommunity-acquired pneumoniaCalcitonin Gene-Related PeptideClinical BiochemistryCochrane LibraryBiochemistryProcalcitoninSepsisCommunity-acquired pneumoniamedicineHumansProtein PrecursorsChildIntensive care medicineChildrenCause of deathPediatric CAPbusiness.industryBiochemistry (medical)BiomarkerGeneral MedicinePneumonia Pneumococcalmedicine.diseaseAnti-Bacterial AgentsCommunity-Acquired InfectionsBiomarkers; Children; Community-acquired pneumonia; PCT; Pediatric CAP; ProcalcitoninPneumoniaPneumococcal infectionsBiomarker (medicine)PCTbusinessProcalcitoninBiomarkershormones hormone substitutes and hormone antagonistsClinica Chimica Acta
researchProduct

Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule

2013

Background: The 7-valent pneumococcal conjugate vaccine (PCV7) has demonstrated effectiveness against pneumococcal illnesses when administered as 3 infant doses plus a toddler dose (3+1 schedule) or as an abbreviated schedule of 2 infant doses plus a toddler dose (2+1 schedule). The 13-valent pneumococcal conjugate vaccine (PCV13) is approved and World Health Organization-prequalified for administration in a 2+1 schedule when used as part of routine immunization programs. Objective: To summarize immunologic responses elicited by PCV13 administered in a 2+1 schedule and following 2 doses in a 3+1 schedule. Methods: Studies were double-blind, randomized, active-controlled, multicenter studies…

MaleSerotypePCV132+12+1; Immune response; PCV13; Pediatric; Pneumococcal conjugate vaccinePneumococcal InfectionsPneumococcal conjugate vaccinePneumococcal VaccinesDouble-Blind MethodHumansMedicineDosingToddlerImmune responseMexicoPediatricGeneral VeterinaryGeneral Immunology and Microbiologybiologybusiness.industryImmunogenicityPneumococcal conjugate vaccineVaccinationPublic Health Environmental and Occupational HealthInfantAntibodies BacterialUnited KingdomClinical trialInfectious DiseasesItalySpainImmunoglobulin GConcomitantImmunologybiology.proteinMolecular MedicineFemaleAntibodybusinessmedicine.drug
researchProduct

Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate …

2011

Background Induction of immunologic memory was assessed following primary vaccination with 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Methods Infants were randomized (1:1) to receive 3 doses of PHiD-CV or 7vCRM (7-valent CRM197-conjugated pneumococcal conjugate vaccine [PCV]) at 2, 3, and 4 months of age followed by 23-valent pneumococcal polysaccharide vaccine (23vPS) booster dose at 11 to 14 months of age. Pneumococcal geometric mean antibody concentrations (GMCs) and opsonophagocytic activity (OPA) geometric mean titers were measured. Results Postprimary immune responses were consistent with those in previous PHiD-CV and 7vCRM studies…

Microbiology (medical)Heptavalent Pneumococcal Conjugate VaccineImmunization SecondaryBooster dosemedicine.disease_causecomplex mixturesPneumococcal conjugate vaccinePneumococcal InfectionsHaemophilus influenzaePneumococcal VaccinesConjugate vaccinemedicineHeptavalent Pneumococcal Conjugate VaccineHumansHepatitis B VaccinesVaccines CombinedDiphtheria-Tetanus-Pertussis VaccineImmunization ScheduleHaemophilus VaccinesVaccines Conjugatebusiness.industryVaccinationInfantOpsonin ProteinsPneumococcal polysaccharide vaccineAntibodies BacterialVaccinationPoliovirus Vaccine InactivatedInfectious DiseasesStreptococcus pneumoniaeTreatment OutcomeImmunizationPediatrics Perinatology and Child HealthImmunologybusinessImmunologic Memorymedicine.drugThe Pediatric infectious disease journal
researchProduct

The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion.

2013

Hajj is the annual pilgrimage to Mecca in the Kingdom of Saudi Arabia, and is one of the largest mass gathering events in the world. Acute respiratory tract infections are very common during Hajj, primarily as a result of close contact among pilgrims, intense congestion, shared accommodation and air pollution. A number of vaccines are (or have been) recommended for Hajj pilgrims in recent years. Several additional vaccines could significantly reduce the morbidity and mortality at Hajj and should be considered in health recommendations for pilgrims. Pneumococcal vaccines (particularly for those aged >65 years) are widely available, and have been shown to reduce the burden of disease associat…

Pediatricsmedicine.medical_specialtyPopulationSaudi ArabiaIslamPneumococcal conjugate vaccinePneumococcal InfectionsPneumococcal VaccinesEnvironmental healthMass gatheringMedicineTravel medicineHumanseducationeducation.field_of_studyTravelRespiratory tract infectionsbusiness.industryReligion and MedicinePublic Health Environmental and Occupational HealthPneumococcal polysaccharide vaccineVaccinationInfectious DiseasesCrowdingHajjbusinessTravel Medicinemedicine.drugTravel medicine and infectious disease
researchProduct

Sepsis due to Streptococcus pneumoniae associated with secondary hemophagocytic lymphohistiocytosis in a splenectomized patient for spherocytosis

2017

Abstract Rationale: Hemophagocytic lymphohistiocytosis (HLH) is a syndrome that is characterized by an inappropriate hyperinflammatory immune response – primary, as a consequence of a genetic defect of NK cells and cytotoxic T lymphocytes or – secondary, in the progression of infections, rheumatic or autoimmune diseases, malignancies or metabolic diseases. Patient concerns: We present the case of a secondary HLH due to Streptococcus pneumoniae infection in a splenectomised patient for spherocytosis, a 37-year-old patient who was splenectomised in childhood for spherocytosis, without immuneprophylaxis induced by antipneumococcal vaccine. Outcomes: He developed a severe pneumococcal sepsis as…

Secondary Hemophagocytic LymphohistiocytosisAdultMaleendocrine systemsplenectomized patientmedicine.medical_treatmentSpherocytosisSplenectomySpherocytosis Hereditarymedicine.disease_causeLymphohistiocytosis HemophagocyticPneumococcal InfectionsSepsis03 medical and health sciences0302 clinical medicineImmune systemFatal Outcomehemic and lymphatic diseasesSepsisStreptococcus pneumoniaemedicineCytotoxic T cellHumans030212 general & internal medicineClinical Case ReportHemophagocytic lymphohistiocytosisbusiness.industry4900General Medicinemedicine.diseaseStreptococcus pneumoniaehemophagocytic lymphohistiocytosis030220 oncology & carcinogenesisImmunologySplenectomybusinessResearch ArticleHLHMedicine
researchProduct